Home Events News Contact Sitemap Help
















 





At some point, most patients will encounter the need for vaccination. Many people question how vaccines are made, if they are effective and whether they are safe. They seek answers to these questions from a wide variety of sources including family, friends, health care providers, the Internet, television and medical literature. The information they receive is complex and, at times, inaccurate or misleading. Therefore, health professionals have a responsibility to provide accurate, understandable information and to handle vaccine safety concerns appropriately.

The National Childhood Vaccine Injury Act (NCVIA) requires all health care providers who administer vaccines to discuss the potential risks and benefits of immunization. Additionally, federal law requires all health care providers who administer vaccines in the United States to provide Vaccine Information Statements (VISs) to vaccine recipients (or their parent/guardian) prior to each dose being administered. VISs are developed by Centers for Disease Control and Prevention (CDC) and contain information on the disease as well as the risks and benefits associated with immunization. These documents, and others, can be obtained from the National Immunization Program (NIP) through the CDC Information Contact Center at 1-800-232-4636 or from the NIP's VIS website.

Back to Top

Home | Public Information | Provider Information | Events Calendar
Newsletter | Contact | Sitemap | Help | Disclaimer | Privacy Policy

© Copyright 2001 Immunization Program Utah Department of Health
All rights reserved

Utah Department of Health




HPV Vaccines

The FDA has approved Cervarix (GlaxoSmithKline) for use in girls
and women ages 10 through 25 years to prevent cervical cancer and precancerous lesions caused by human papillomavirus (HPV) types 16 and 18. Women who are
pregnant, or think that they may be pregnant, or plan to become pregnant during the vaccination course, should not use Cervarix. Click here to read more.

The FDA has approved use of the vaccine Gardasil (Merck) for the prevention of genital warts
(condyloma acuminata) due to human papillomavirus (HPV)
types 6 and 11 in boys and men, ages 9 through 26. Click here to read more.

 



Autism Information
Adult Immunizations
Current Issues
Flu Vaccine Supply
Human Papillomavirus (HPV)
Parents Guide
Schedules/
Recommendations
Statewide Clinics
Travel Information

Utah Statewide Immunization
  Information System (USIIS)